- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Operational characteristics Of 11 C-choline PET/CT for prostate cancer patients with biochemical recurrence following initial treatment - Abstract
December 3, 2012
Diabetes mellitus and risk of prostate cancer: An updated meta-analysis based on 12 case-control and 25 cohort studies - Abstract
December 3, 2012
Clinical benefits of alpharadin in castrate-chemotherapy-resistant prostate cancer: Case report and literature review - Abstract
December 3, 2012
Fasting blood glucose and lipid profile alterations following twelve-month androgen deprivation therapy in men with prostate cancer - Abstract
December 3, 2012
Stratification of postprostatectomy urinary function using Expanded Prostate Cancer Index Composite - Abstract
December 1, 2012
Overcoming docetaxel resistance in prostate cancer: A perspective review - Abstract
November 30, 2012
Mood and cognitive disorders, and androgen deprivation - Abstract
November 30, 2012
Prostate cancer imaging: What the urologist wants to know - Abstract
November 30, 2012
Imaging prostate cancer - Abstract
November 30, 2012
Role of transrectal ultrasonography in prostate cancer - Abstract
November 30, 2012
Imaging of recurrent prostate cancer - Abstract
November 30, 2012
Risk factors for metastatic castration-resistant prostate cancer (CRPC) predict long-term treatment with docetaxel - Abstract
November 29, 2012
Prostate cancer in elderly subjects: How diagnosis should be made, why and how geriatric assessment should be implemented - Abstract
November 29, 2012
The Prostate Cancer Registry: Monitoring patterns and quality of care for men diagnosed with prostate cancer - Abstract
November 29, 2012
Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? - Abstract
November 29, 2012
Perineal radical prostatectomy in the minimally invasive era - Abstract
November 29, 2012